Dr. Alex Li advises clients around the world on a wide range of matters that involve complex scientific and technical issues. His practice includes both emerging companies and multinational corporations in the chemical, pharmaceutical, biotechnology, semiconductor, and software sectors.
Alex's experience includes patent prosecution, freedom-to-operate analysis, software licensing, IP due diligence, IP agreements, cross-border IP transactions, and Hatch-Waxman litigations.
In assisting clients, Alex draws on his significant technical knowledge and research experience from his graduate studies in chemistry. He has authored a number of peer-reviewed scientific publications on subjects such as asymmetric catalysis, computational molecular modeling, and quantum dots. Prior to joining Jones Day, Alex worked as a patent agent for several law firms in the Washington, D.C. area.
ITC Allows Respondent to Amend Response to Complaint to Include Defense of Inequitable Conduct, ITC Blog
ITC Concludes Early Disposition Program Not Appropriate for Subject Matter Eligibility and Domestic Industry, ITC Blog
Precedential: PTAB Denies Co-Defendant’s Petitions As Unfair Follow-On Petitions, PTAB Litigation Blog
- Georgetown University (J.D. 2018; Senior Student Editor, Food and Drug Law Journal); Yale University (Ph.D. 2013; M.S. in Organic Chemistry 2009); University of Cambridge (M.A. 2010; M.Sci. 2007; B.A. in Natural Sciences 2007)
- District of Columbia, Virginia, and registered to practice before the United States Patent and Trademark Office